0
2019.
– COMPARISON OF CELLULAR RESPONSE OF TREATED MDA-MB231 BREAST CELLS REPOSITIONING EXISTING DRUGS AS NOVEL THERAPEUTICS FOR HIGH-RISK PAEDIATRIC LEUKAEMIA